Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
AlphaMark Actively Managed Small Cap ETF | SMCP | Sep 27, 2024 | 32.91 | +0.78 |
Alphatec | ATEC | Sep 27, 2024 | 5.56 | +1.28 |
AlphaTime Acquisition | ATMC | Sep 27, 2024 | 11.20 | 0.00 |
AlphaVest Acquisition | ATMV | Sep 27, 2024 | 11.13 | 0.00 |
AlphaVest Acquisition Unit | ATMVU | Sep 27, 2024 | 12.32 | 0.00 |
Alpine 4 A | ALPP | Sep 27, 2024 | 0.34 | +2.13 |
Alpine Income Property | PINE | Sep 27, 2024 | 18.25 | +0.39 |
Alps Alerian MLP ETF | AMLP | Sep 27, 2024 | 46.99 | +0.71 |
Alps Equal Sector Weight ETF | EQL | Sep 27, 2024 | 127.19 | +0.33 |
Alps International Sector Divid | IDOG | Sep 27, 2024 | 32.07 | +0.53 |
Alps Sector Dividend Dogs ETF | SDOG | Sep 27, 2024 | 58.82 | +0.39 |
Alset EHome International | AEI | Sep 27, 2024 | 1.50 | +36.36 |
Alt5 Sigma | ALTS | Sep 27, 2024 | 1.81 | 0.00 |
Alta Equipment A Pref | ALTG-A | Sep 27, 2024 | 25.50 | -0.25 |
Alta Equipment Group A | ALTG | Sep 27, 2024 | 6.51 | +1.24 |
Alta Global Group | MMA | Sep 27, 2024 | 1.94 | +10.54 |
Altair Engineering A | ALTR | Sep 27, 2024 | 94.87 | -0.20 |
Altamira Therapeutics | CYTO | Sep 27, 2024 | 0.67 | +0.95 |
AltEnergy Acquisition A | AEAE | Sep 27, 2024 | 11.11 | 0.00 |
AltEnergy Acquisition Unit | AEAEU | Sep 27, 2024 | 11.06 | 0.00 |
Alterity Therapeutics ADR | ATHE | Sep 27, 2024 | 1.33 | +6.85 |
Alternus Clean Energy A | ALCE | Sep 27, 2024 | 0.16 | -2.02 |
Alti Global A | ALTI | Sep 27, 2024 | 3.80 | -0.26 |
Altice USA A | ATUS | Sep 27, 2024 | 2.50 | +1.21 |
Altimmune | ALT | Sep 27, 2024 | 6.47 | -4.99 |
Altisource Asset Management | AAMC | Sep 27, 2024 | 1.31 | 0.00 |
Altisource Portfolio Solutions | ASPS | Sep 27, 2024 | 1.19 | +6.25 |
Alto Ingredients | ALTO | Sep 27, 2024 | 1.64 | -2.38 |
Alto Neuroscience | ANRO | Sep 27, 2024 | 12.10 | +0.83 |
Altria Group | MO | Sep 27, 2024 | 51.05 | -0.08 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.